Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation-Reference-Cited by-同舟云学术

Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation

Published:1990-11 Issue:15 Volume:66 Page:1135-1138
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Rudas Laszlo,Pflugfelder Peter W.,McKenzie F.Neil,Menkis Alan H.,Novick Richard J.,Kostuk William J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Accelerated coronary atherosclerosis in cardiac transplantation;Eich,1990

2. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone;Uretsky;Circulation,1987

3. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings;Gao;J Am Coll Cardiol,1988

4. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation;O'Neill;Am J Cardiol,1989

5. Studies on pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia;Alonso;Am J Pathol,1977

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation;CJC Open;2021-12

2. Weight gain post–heart transplantation is associated with an increased risk for allograft vasculopathy and rejection;Clinical Transplantation;2020-12-19

3. Acute and chronic phagocyte determinants of cardiac allograft vasculopathy;Seminars in Immunopathology;2018-08-23

4. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients;ESC Heart Failure;2018-07-17

5. Corticosteroids—glucocorticoids;Meyler's Side Effects of Drugs;2016